Metronomic Maintenance Therapy in Refractory Acute Myeloblastic Leukemia with Monosomy 7
Journal Title: Iranian Journal of Blood and Cancer - Year 2015, Vol 7, Issue 5
Abstract
Patients with acute myeloblastic leukemia (AML) with monosomy 7 are a group of patients with refractory AML who have a very poor prognosis. Therefore, rationally designed new therapies, including metronomic chemotherapy regimen with histidine deacetylase inhibitors (Valporic acid, ATRA) are being investigated as potential treatments for the population of refractory cases of AML. Herein, we report a patient with primary refractory AML who was treated with oral low-dose chemotherapy after standard systemic chemotherapy.
Authors and Affiliations
Mahdi Shahriari, Babak Abdolkarimi, Fazl Saleh, Pooria Salajeghe
Keywords
Related Articles
- EP ID EP281474
- DOI -
- Views 89
- Downloads 0
Determination of Monosomy 7 among In Vitro Generated CD1a Positive Cells in Patients with Juvenile Myelomonocytic Leukemia
Objective: To study whether the generated CD1a positive cells belong to the leukemic cells among patients with juvenile myelomonocytic leukemia. Materials and Methods: We used mononuclear cells from 3 patients with juven...
Plasma Fractionation Industry Project in Turkey: Country’s Experiences
This article has no abstract.
Worldwide Supply and Demand of Plasma And Plasma-Derived Medicines
This article has no abstract.
Fava Bean Ingestion: the Most Important Risk Factor of Hemolysis in G6PD Deficiency in Iran
Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is one of the most known enzyme defects in Iran with various genetic mutations. We aimed to study the predisposing factors of hemolysis in children with G6P...
Platelet Satellitism in a Three and Half Year Old Girl with Hemolytic Anemia and Normal Platelet Count
Platelet adherence surrounding leucocytes in a rosette formation or platelet satellitism is a rare phenomenon. This finding has been observed almost exclusively in Ethylenediaminetetraacetic acid treated blood at room te...